Literature DB >> 16983469

Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe.

Yasuhiro Ito1, Tomoo Jikuzono, Takuya Higashiyama, Shuji Asahi, Chisato Tomoda, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Kanji Kuma, Akira Miyauchi.   

Abstract

BACKGROUND: Previous studies have shown that lymph node metastasis can be of prognostic value. In this study, we investigated the clinical significance of node metastasis focusing on metastasis in the central compartment for patients with papillary carcinoma located in one lobe. PATIENTS AND METHODS: We investigated the frequency of lymph node metastasis in 759 patients with papillary carcinoma to determine whether and how such metastasis affects disease-free survival (DFS).
RESULTS: Central node metastasis was observed in 63% of patients, and the frequency was increased in relation to tumor size. The frequency of lateral node metastasis was 62.0%, which was also directly related to tumor size. On multivariate analysis of cases showing tumor larger than 1 cm, central node metastasis was recognized as an independent prognostic factor of DFS. The frequency of metastasis to the paratracheal nodes contralateral to the tumor was drastically elevated for tumors larger than 1 cm, but metastasis to this region did not independently predict worse DFS.
CONCLUSION: Central node metastasis independently predicts a worse DFS for patients with papillary carcinoma larger than 1 cm.

Entities:  

Mesh:

Year:  2006        PMID: 16983469     DOI: 10.1007/s00268-006-0211-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  [Prognostically relevant factors in papillary thyroid cancer].

Authors:  T Böttger; J Klupp; H E Gabbert; T Junginger
Journal:  Med Klin (Munich)       Date:  1991-02-15

2.  Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer.

Authors:  Takashi Uruno; Akira Miyauchi; Kazuo Shimizu; Chisato Tomoda; Yuuki Takamura; Yasuhiro Ito; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Nobuyuki Amino; Kanji Kuma
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

3.  Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

4.  Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

5.  Impact of neck dissection on survival in well-differentiated thyroid cancer: a multivariate analysis of 218 cases.

Authors:  M Noguchi; T Kumaki; T Taniya; M Segawa; T Nakano; N Ohta; I Miyazaki
Journal:  Int Surg       Date:  1990 Oct-Dec

6.  Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer.

Authors:  G F Scheumann; O Gimm; G Wegener; H Hundeshagen; H Dralle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

7.  Skip metastases in thyroid cancer leaping the central lymph node compartment.

Authors:  Andreas Machens; Hans-Jürgen Holzhausen; Henning Dralle
Journal:  Arch Surg       Date:  2004-01

8.  Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.

Authors:  E L Mazzaferri; R L Young
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

9.  Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system.

Authors:  H Salvesen; P R Njølstad; L A Akslen; G Albrektsen; O Søreide; J E Varhaug
Journal:  Eur J Surg       Date:  1992 Nov-Dec

10.  Prognostic importance of various clinicopathological features in papillary thyroid carcinoma.

Authors:  L A Akslen; A O Myking; H Salvesen; J E Varhaug
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

View more
  58 in total

Review 1.  Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

2.  Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.

Authors:  Laura Y Wang; Frank L Palmer; Iain J Nixon; R Michael Tuttle; Jatin P Shah; Snehal G Patel; Ashok R Shaha; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2015-02-10       Impact factor: 5.344

Review 3.  Central lymph node dissection in differentiated thyroid cancer.

Authors:  Matthew L White; Paul G Gauger; Gerard M Doherty
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 4.  Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists.

Authors:  Mark L Urken; Jeffery I Mechanick; Jonathan Sarlin; Sophie Scherl; Bruce M Wenig
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

5.  Lobectomy and prophylactic central neck dissection for papillary thyroid microcarcinoma: do involved lymph nodes mandate completion thyroidectomy?

Authors:  Cho Rok Lee; Haiyoung Son; Sohee Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

6.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

7.  Role of RAI in the management of incidental N1a disease in papillary thyroid cancer.

Authors:  Laura Y Wang; Frank L Palmer; Jocelyn C Migliacci; Iain J Nixon; Ashok R Shaha; Jatin P Shah; Robert Michael Tuttle; Snehal G Patel; Ian Ganly
Journal:  Clin Endocrinol (Oxf)       Date:  2015-07-03       Impact factor: 3.478

8.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

Review 9.  Nodal metastases in thyroid cancer: prognostic implications and management.

Authors:  Laura Y Wang; Ian Ganly
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

10.  Thyroidectomy and lymph node dissection in papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2010-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.